| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 HYOU1 MYO7A SMC6 PEX1 KIF4A ABCC11 CHD2 INO80 ATP10D DHX8 ATP2C1 ATP2B1 ATP2B3 ATP2B4 DNAH11 | 2.22e-07 | 614 | 109 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.69e-07 | 11 | 109 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 SMC6 PEX1 ABCC11 CHD2 INO80 ATP10D DHX8 ATP2C1 ATP2B1 ATP2B3 ATP2B4 DNAH11 | 8.52e-07 | 441 | 109 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 SMC6 LRRK2 PEX1 ABCC11 CHD2 INO80 RGS7 ATP10D DHX8 ATP2C1 ATP2B1 ATP2B3 ATP2B4 DNAH11 | 2.03e-05 | 775 | 109 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 4.33e-05 | 36 | 109 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 4.33e-05 | 36 | 109 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 SMC6 LRRK2 PEX1 ABCC11 CHD2 INO80 RGS7 ATP10D DHX8 ATP2C1 ATP2B1 ATP2B3 ATP2B4 DNAH11 | 5.06e-05 | 839 | 109 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 SMC6 LRRK2 PEX1 ABCC11 CHD2 INO80 RGS7 ATP10D DHX8 ATP2C1 ATP2B1 ATP2B3 ATP2B4 DNAH11 | 5.13e-05 | 840 | 109 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 SMC6 LRRK2 PEX1 ABCC11 CHD2 INO80 RGS7 ATP10D DHX8 ATP2C1 ATP2B1 ATP2B3 ATP2B4 DNAH11 | 5.13e-05 | 840 | 109 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 1.86e-04 | 52 | 109 | 4 | GO:0043014 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RAG1 CMTR1 TUT7 ZC3H12B CHD2 INO80 ANKZF1 HMCES DHX8 EXD2 NOCT REV1 | 2.10e-04 | 645 | 109 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 2.20e-04 | 100 | 109 | 5 | GO:0019888 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 2.92e-04 | 5 | 109 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO7A TPRN LRRK2 TRIOBP KIF4A GAS7 ACTN2 DNAL1 INO80 MAGI2 PPP2R2A LMO7 TRPV4 EML1 TRAPPC14 MYBPC1 | 3.03e-04 | 1099 | 109 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.29e-04 | 109 | 109 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 3.67e-04 | 62 | 109 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 3.89e-04 | 113 | 109 | 5 | GO:0019208 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 5.21e-04 | 29 | 109 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.73e-04 | 123 | 109 | 5 | GO:0030165 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 7.66e-04 | 33 | 109 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | actin binding | 1.25e-03 | 479 | 109 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.25e-03 | 39 | 109 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.44e-03 | 151 | 109 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.65e-03 | 230 | 109 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | titin binding | 2.57e-03 | 14 | 109 | 2 | GO:0031432 | |
| GeneOntologyCellularComponent | stereocilium base | 7.58e-06 | 8 | 109 | 3 | GO:0120044 | |
| Domain | ATP_Ca_trans_C | 7.70e-07 | 4 | 109 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 7.70e-07 | 4 | 109 | 3 | PF12424 | |
| Domain | P-type_ATPase_IIB | 7.70e-07 | 4 | 109 | 3 | IPR006408 | |
| Domain | ATPase_P-typ_TM_dom | 1.89e-06 | 16 | 109 | 4 | IPR023298 | |
| Domain | - | 1.89e-06 | 16 | 109 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_P_site | 2.01e-06 | 36 | 109 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 2.01e-06 | 36 | 109 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.01e-06 | 36 | 109 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.32e-06 | 37 | 109 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.32e-06 | 37 | 109 | 5 | PF00122 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.46e-06 | 17 | 109 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.46e-06 | 17 | 109 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 3.15e-06 | 18 | 109 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 3.15e-06 | 18 | 109 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.98e-06 | 19 | 109 | 4 | IPR004014 | |
| Domain | ATP2B1/4 | 3.37e-05 | 2 | 109 | 2 | IPR030319 | |
| Domain | ATPase_P-typ_cyto_domN | 5.00e-05 | 35 | 109 | 4 | IPR023299 | |
| Domain | HAD-like_dom | 9.87e-05 | 79 | 109 | 5 | IPR023214 | |
| Domain | Ankyrin_rpt-contain_dom | 1.22e-04 | 254 | 109 | 8 | IPR020683 | |
| Domain | Ankyrin_rpt | 1.51e-04 | 262 | 109 | 8 | IPR002110 | |
| Domain | WW | 1.61e-04 | 47 | 109 | 4 | PF00397 | |
| Domain | WW | 1.75e-04 | 48 | 109 | 4 | SM00456 | |
| Domain | WW_DOMAIN_1 | 2.22e-04 | 51 | 109 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.22e-04 | 51 | 109 | 4 | PS50020 | |
| Domain | WW_dom | 2.40e-04 | 52 | 109 | 4 | IPR001202 | |
| Domain | P-loop_NTPase | DNAH3 MYO7A SMC6 LRRK2 PEX1 KIF4A ABCC11 CHD2 INO80 DHX8 MAGI2 SAMD9L GIMAP8 DNAH11 | 4.14e-04 | 848 | 109 | 14 | IPR027417 |
| Domain | - | 6.31e-04 | 248 | 109 | 7 | 1.25.40.20 | |
| Domain | ANK | 6.78e-04 | 251 | 109 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 7.10e-04 | 253 | 109 | 7 | PS50088 | |
| Domain | ANK_REP_REGION | 7.27e-04 | 254 | 109 | 7 | PS50297 | |
| Domain | - | DNAH3 MYO7A SMC6 LRRK2 PEX1 ABCC11 CHD2 INO80 DHX8 SAMD9L GIMAP8 DNAH11 | 1.36e-03 | 746 | 109 | 12 | 3.40.50.300 |
| Domain | Leu-rich_rpt_4 | 1.47e-03 | 10 | 109 | 2 | IPR025875 | |
| Domain | LRR_4 | 1.47e-03 | 10 | 109 | 2 | PF12799 | |
| Domain | Hydrolase_3 | 1.47e-03 | 10 | 109 | 2 | PF08282 | |
| Domain | Ank | 2.21e-03 | 228 | 109 | 6 | PF00023 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.93e-03 | 14 | 109 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.93e-03 | 14 | 109 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.93e-03 | 14 | 109 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.93e-03 | 14 | 109 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.93e-03 | 14 | 109 | 2 | IPR011704 | |
| Domain | MT | 2.93e-03 | 14 | 109 | 2 | PF12777 | |
| Domain | AAA_8 | 2.93e-03 | 14 | 109 | 2 | PF12780 | |
| Domain | AAA_5 | 2.93e-03 | 14 | 109 | 2 | PF07728 | |
| Domain | DHC_fam | 3.37e-03 | 15 | 109 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.37e-03 | 15 | 109 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.37e-03 | 15 | 109 | 2 | IPR004273 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.48e-06 | 183 | 78 | 8 | M997 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.28e-05 | 55 | 78 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.52e-05 | 57 | 78 | 5 | MM15643 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.46e-05 | 12 | 78 | 3 | M27326 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.26e-05 | 176 | 78 | 7 | MM15718 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 5.68e-05 | 14 | 78 | 3 | MM15052 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 2.66e-04 | 23 | 78 | 3 | M913 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.33e-04 | 27 | 78 | 3 | MM15053 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.33e-04 | 27 | 78 | 3 | M47755 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.83e-04 | 28 | 78 | 3 | M924 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 8.23e-04 | 76 | 78 | 4 | MM15051 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 8.64e-04 | 77 | 78 | 4 | M41822 | |
| Pubmed | 7.06e-09 | 8 | 112 | 4 | 10951186 | ||
| Pubmed | FBRSL1 TRIOBP INO80 BCOR ANKHD1 ANKLE2 PPP2R2A PPP2R5C SYNJ2 LMO7 MIB1 CEP126 WNK2 | 1.74e-08 | 529 | 112 | 13 | 14621295 | |
| Pubmed | TPP2 PDE1C HYOU1 MYO7A ACTN2 MAGI2 PPP2R2A SACS LMO7 MTERF2 GLO1 OSBPL10 ERC2 PLCH1 ATP2B1 ATP2B3 ATP2B4 ARHGAP21 WNK2 DNAH11 | 2.99e-08 | 1431 | 112 | 20 | 37142655 | |
| Pubmed | 3.53e-08 | 29 | 112 | 5 | 15071553 | ||
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 1.30e-07 | 4 | 112 | 3 | 12209837 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 12784250 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 1.30e-07 | 4 | 112 | 3 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 1.30e-07 | 4 | 112 | 3 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 1.30e-07 | 4 | 112 | 3 | 11152753 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 1.30e-07 | 4 | 112 | 3 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 1.30e-07 | 4 | 112 | 3 | 10434059 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 15101689 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 1.30e-07 | 4 | 112 | 3 | 8634322 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 17938178 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 6.46e-07 | 6 | 112 | 3 | 12767889 | |
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 11956189 | ||
| Pubmed | LMO7 deficiency reveals the significance of the cuticular plate for hearing function. | 1.80e-06 | 8 | 112 | 3 | 30850599 | |
| Pubmed | HYOU1 CHD2 ACTN2 ANKLE2 SEC61A2 PSME3IP1 SACS LMO7 ANKRD30A ERC2 PLCH1 ATP2B1 ATP2B3 OBI1 ARHGAP21 ERICH6 MYBPC1 | 3.72e-06 | 1442 | 112 | 17 | 35575683 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TPP2 HYOU1 CMTR1 TUT7 BCKDK PEX1 PPP2R2A ATP2C1 LMO7 MIB1 ATP2B1 ATP2B4 | 6.04e-06 | 754 | 112 | 12 | 33060197 |
| Pubmed | TPP2 HYOU1 TPRN BCKDK TRIOBP BCOR ANKLE2 PPP2R2A PPP2R5C PRPF3 MIB1 PDZD8 ATP2B1 ATP2B4 | 7.31e-06 | 1049 | 112 | 14 | 27880917 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 18657858 | ||
| Pubmed | TRPV4 heats up ANO1-dependent exocrine gland fluid secretion. | 1.03e-05 | 2 | 112 | 2 | 29187363 | |
| Pubmed | Modulation of water efflux through functional interaction between TRPV4 and TMEM16A/anoctamin 1. | 1.03e-05 | 2 | 112 | 2 | 24509911 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 34051020 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 1531651 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15178683 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19144698 | ||
| Pubmed | Identification of protein phosphatase 2A as an interacting protein of leucine-rich repeat kinase 2. | 1.03e-05 | 2 | 112 | 2 | 26894577 | |
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 1.03e-05 | 2 | 112 | 2 | 10748016 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32906142 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23266958 | ||
| Pubmed | The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. | 1.03e-05 | 2 | 112 | 2 | 16412504 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16956963 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 1674727 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16291816 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26116539 | ||
| Pubmed | AHI1 HYOU1 TUT7 SMC6 PEX1 CHD2 INO80 TEC BCOR ANKHD1 ANKLE2 PPP2R5C ATP2B1 ARHGAP21 | 1.06e-05 | 1084 | 112 | 14 | 11544199 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.43e-05 | 444 | 112 | 9 | 34795231 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HYOU1 CMTR1 SMC6 TRIOBP INO80 ANKHD1 DHX8 PPP2R2A SYNJ2 LMO7 EIF5 | 2.31e-05 | 724 | 112 | 11 | 36232890 |
| Pubmed | CASC3 BCKDK TRIOBP KIF4A CHD2 INO80 BCOR ANKHD1 ANKZF1 DNAJC2 DHX8 PPP2R5C TCERG1 EXD2 EIF5 EIF2AK2 | 2.47e-05 | 1497 | 112 | 16 | 31527615 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 32610123 | ||
| Pubmed | The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions. | 3.08e-05 | 3 | 112 | 2 | 35932995 | |
| Pubmed | Crosstalk among Calcium ATPases: PMCA, SERCA and SPCA in Mental Diseases. | 3.08e-05 | 3 | 112 | 2 | 33801794 | |
| Pubmed | A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation. | 3.08e-05 | 3 | 112 | 2 | 28827723 | |
| Pubmed | Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. | 3.08e-05 | 3 | 112 | 2 | 20639879 | |
| Pubmed | Zinc finger protein Zfp335 is required for the formation of the naïve T cell compartment. | 3.08e-05 | 3 | 112 | 2 | 25343476 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 33098669 | ||
| Pubmed | IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in L. donovani Infected Mice. | 3.08e-05 | 3 | 112 | 2 | 32038622 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 26046638 | ||
| Pubmed | Role of PKR and Type I IFNs in viral control during primary and secondary infection. | 3.08e-05 | 3 | 112 | 2 | 20585572 | |
| Pubmed | CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. | 3.08e-05 | 3 | 112 | 2 | 15133509 | |
| Pubmed | AHI1 TUT7 SMC6 ANKHD1 SLC10A7 PSME3IP1 EIF5 TRAPPC14 ATP2B4 OBI1 MYBPC1 | 3.18e-05 | 750 | 112 | 11 | 11230166 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ARID4B TUT7 BCKDK SMC6 KIF4A DHX8 NUFIP1 TCERG1 PRPF3 ERC2 EIF2AK2 | 3.54e-05 | 759 | 112 | 11 | 35915203 |
| Pubmed | 4.79e-05 | 22 | 112 | 3 | 12812986 | ||
| Pubmed | HYOU1 TUT7 FBRSL1 PEX1 ANKHD1 ANKZF1 TCERG1 OSBPL10 PLCH1 ARHGAP21 | 4.97e-05 | 650 | 112 | 10 | 38777146 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 18029012 | ||
| Pubmed | IRF-5 Promotes Cell Death in CD4 T Cells during Chronic Infection. | 6.14e-05 | 4 | 112 | 2 | 30067973 | |
| Pubmed | Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. | 6.14e-05 | 4 | 112 | 2 | 21253574 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 36674959 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 25556170 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 25512391 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 16735509 | ||
| Pubmed | ARID4B TPRN FBRSL1 PEX1 GAS7 INO80 BCOR ANKHD1 NUFIP1 PPP2R2A TCHH ATP2C1 PRPF3 | 6.43e-05 | 1116 | 112 | 13 | 31753913 | |
| Pubmed | 6.85e-05 | 421 | 112 | 8 | 36976175 | ||
| Pubmed | BAZ2B LRRK2 CHD2 ANKHD1 RGS7 SEC61A2 SAMD9L EXD2 CEP126 IQUB | 7.77e-05 | 686 | 112 | 10 | 29987050 | |
| Pubmed | SoxC transcription factors are essential for the development of the inner ear. | 1.02e-04 | 5 | 112 | 2 | 26504244 | |
| Pubmed | Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice. | 1.02e-04 | 5 | 112 | 2 | 18258656 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 17529992 | ||
| Pubmed | PP2A is required for centromeric localization of Sgo1 and proper chromosome segregation. | 1.02e-04 | 5 | 112 | 2 | 16580887 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CASC3 TCERG1 SYNJ2 LMO7 EIF5 OSBPL10 TRAPPC14 PLCH1 ATP2B1 OBI1 ARHGAP21 | 1.09e-04 | 861 | 112 | 11 | 36931259 |
| Pubmed | 1.12e-04 | 233 | 112 | 6 | 37704626 | ||
| Pubmed | LRRC39 AHI1 TUT7 SMC6 TRIOBP SLC10A7 PSME3IP1 TRAPPC14 ATP2B4 MYBPC1 | 1.15e-04 | 720 | 112 | 10 | 16381901 | |
| Pubmed | LRRC39 AHI1 TUT7 SMC6 TRIOBP SLC10A7 PSME3IP1 TRAPPC14 ATP2B4 MYBPC1 | 1.18e-04 | 722 | 112 | 10 | 15489336 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 1.42e-04 | 468 | 112 | 8 | 31056421 | |
| Pubmed | 1.53e-04 | 6 | 112 | 2 | 12763866 | ||
| Pubmed | 1.53e-04 | 6 | 112 | 2 | 18385676 | ||
| Pubmed | The chromosomal association of condensin II is regulated by a noncatalytic function of PP2A. | 1.53e-04 | 6 | 112 | 2 | 19915589 | |
| Pubmed | Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses. | 1.53e-04 | 6 | 112 | 2 | 25149452 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.63e-04 | 357 | 112 | 7 | 37059091 | |
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 24786772 | ||
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 9256245 | ||
| Pubmed | POST, partner of stromal interaction molecule 1 (STIM1), targets STIM1 to multiple transporters. | 2.14e-04 | 7 | 112 | 2 | 22084111 | |
| Pubmed | 2.29e-04 | 638 | 112 | 9 | 31182584 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.53e-04 | 38 | 112 | 3 | 30786075 | |
| Pubmed | LRRC39 AHI1 TUT7 SMC6 TRIOBP SLC10A7 PSME3IP1 TRAPPC14 ATP2B4 MYBPC1 | 2.54e-04 | 794 | 112 | 10 | 11076863 | |
| Pubmed | 2.84e-04 | 8 | 112 | 2 | 28209736 | ||
| Pubmed | Mice deficient in alpha-actinin-4 have severe glomerular disease. | 2.84e-04 | 8 | 112 | 2 | 12782671 | |
| Pubmed | Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. | 2.84e-04 | 8 | 112 | 2 | 28158275 | |
| Pubmed | 2.84e-04 | 8 | 112 | 2 | 17245430 | ||
| Pubmed | TPP2 CASC3 TRIOBP KIF4A BCOR MAGI2 ERC2 EML1 ATP2B4 ARHGAP21 WNK2 | 2.86e-04 | 963 | 112 | 11 | 28671696 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CASC3 TUT7 FBRSL1 CHD2 ANKHD1 DHX8 TCERG1 PRPF3 EIF5 EIF2AK2 | 2.88e-04 | 807 | 112 | 10 | 22681889 |
| Pubmed | 3.65e-04 | 9 | 112 | 2 | 30595372 | ||
| Pubmed | 3.65e-04 | 9 | 112 | 2 | 18432318 | ||
| Pubmed | 3.65e-04 | 9 | 112 | 2 | 12660151 | ||
| Pubmed | Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression. | 3.65e-04 | 9 | 112 | 2 | 23345399 | |
| Pubmed | 3.65e-04 | 9 | 112 | 2 | 20042577 | ||
| Pubmed | 3.65e-04 | 9 | 112 | 2 | 16239230 | ||
| Pubmed | ZMYND10 stabilizes intermediate chain proteins in the cytoplasmic pre-assembly of dynein arms. | 3.65e-04 | 9 | 112 | 2 | 29601588 | |
| GeneFamily | ATPases Ca2+ transporting | 3.39e-08 | 9 | 75 | 4 | 1209 | |
| GeneFamily | Ankyrin repeat domain containing | 6.46e-05 | 242 | 75 | 7 | 403 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 1.72e-03 | 15 | 75 | 2 | 696 | |
| GeneFamily | Dyneins, axonemal | 2.22e-03 | 17 | 75 | 2 | 536 | |
| GeneFamily | DNA helicases | 2.22e-03 | 17 | 75 | 2 | 1167 | |
| GeneFamily | Regulators of G-protein signaling | 3.39e-03 | 21 | 75 | 2 | 720 | |
| GeneFamily | PDZ domain containing | 3.67e-03 | 152 | 75 | 4 | 1220 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-08 | 194 | 112 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.23e-07 | 167 | 112 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-07 | 179 | 112 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.81e-07 | 197 | 112 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.54e-07 | 200 | 112 | 7 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.27e-06 | 168 | 112 | 6 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 182 | 112 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.98e-06 | 183 | 112 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-06 | 185 | 112 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 7.90e-06 | 187 | 112 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.39e-06 | 189 | 112 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.39e-06 | 189 | 112 | 6 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.18e-06 | 192 | 112 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.74e-06 | 194 | 112 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-05 | 196 | 112 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 197 | 112 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.09e-05 | 198 | 112 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 112 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-05 | 126 | 112 | 5 | ec32bfd6cd93fbe02f7577893c82b04d209a52e7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.88e-05 | 150 | 112 | 5 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.88e-05 | 150 | 112 | 5 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-05 | 78 | 112 | 4 | d5e2e2e04e380b265b2530e93cba6f98ad329e4f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.12e-05 | 159 | 112 | 5 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-05 | 169 | 112 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 7.43e-05 | 172 | 112 | 5 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-05 | 173 | 112 | 5 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-05 | 173 | 112 | 5 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-05 | 173 | 112 | 5 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | CV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 7.84e-05 | 174 | 112 | 5 | 26544cc5f51cb4dc1251e62d9f80b6c956194d38 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-05 | 174 | 112 | 5 | 81ab196e36cac2a7974d6e3fe457efffddfd03bb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-05 | 178 | 112 | 5 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 8.96e-05 | 179 | 112 | 5 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.20e-05 | 180 | 112 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.20e-05 | 180 | 112 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 181 | 112 | 5 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 181 | 112 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 181 | 112 | 5 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 181 | 112 | 5 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 9.69e-05 | 182 | 112 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-04 | 185 | 112 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.05e-04 | 185 | 112 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 186 | 112 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 186 | 112 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 186 | 112 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 187 | 112 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 188 | 112 | 5 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 189 | 112 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.16e-04 | 189 | 112 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.19e-04 | 190 | 112 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-04 | 191 | 112 | 5 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.22e-04 | 191 | 112 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 191 | 112 | 5 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.22e-04 | 191 | 112 | 5 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 191 | 112 | 5 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 191 | 112 | 5 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.25e-04 | 192 | 112 | 5 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.25e-04 | 192 | 112 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.25e-04 | 192 | 112 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.25e-04 | 192 | 112 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.28e-04 | 193 | 112 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.28e-04 | 193 | 112 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 193 | 112 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-04 | 194 | 112 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.31e-04 | 194 | 112 | 5 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.31e-04 | 194 | 112 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-04 | 194 | 112 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.31e-04 | 194 | 112 | 5 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 112 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.31e-04 | 194 | 112 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.34e-04 | 195 | 112 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | Mild-NK|Mild / Disease group and Cell class | 1.34e-04 | 195 | 112 | 5 | be88a7507cd6a0a9dfe424312d9365039eef7b74 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 195 | 112 | 5 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.34e-04 | 195 | 112 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 195 | 112 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 195 | 112 | 5 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 195 | 112 | 5 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.34e-04 | 195 | 112 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.34e-04 | 195 | 112 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.37e-04 | 196 | 112 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.40e-04 | 197 | 112 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | B_cells-Memory_B_cells|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.40e-04 | 197 | 112 | 5 | cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.40e-04 | 197 | 112 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.44e-04 | 198 | 112 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.51e-04 | 200 | 112 | 5 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 200 | 112 | 5 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-04 | 200 | 112 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.51e-04 | 200 | 112 | 5 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-04 | 200 | 112 | 5 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.51e-04 | 200 | 112 | 5 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.51e-04 | 200 | 112 | 5 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| Drug | 1sqc | 1.06e-07 | 10 | 110 | 4 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 1.66e-07 | 11 | 110 | 4 | CID000008718 | |
| Drug | AC1L1IZE | 2.43e-07 | 131 | 110 | 8 | CID000004799 | |
| Drug | 1vyq | 2.48e-07 | 12 | 110 | 4 | CID004369390 | |
| Drug | Ro 46861 | 2.48e-07 | 12 | 110 | 4 | CID000003128 | |
| Drug | p-hydroxyhippuric acid | 4.97e-07 | 14 | 110 | 4 | CID000151012 | |
| Drug | AC1L88YH | 1.17e-06 | 17 | 110 | 4 | CID000374551 | |
| Drug | XeC compound | 3.32e-06 | 84 | 110 | 6 | CID000005701 | |
| Drug | AC1L1G0K | 3.87e-06 | 49 | 110 | 5 | CID000003473 | |
| Drug | AC1L25Y6 | 4.25e-06 | 23 | 110 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 4.25e-06 | 23 | 110 | 4 | CID000165791 | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HG-U133A | 5.25e-06 | 197 | 110 | 8 | 203_UP | |
| Drug | cyhexatin | 6.03e-06 | 25 | 110 | 4 | CID005364545 | |
| Drug | dodecyl ether | 7.10e-06 | 26 | 110 | 4 | CID000020667 | |
| Drug | octaethylene glycol | 1.12e-05 | 29 | 110 | 4 | CID000078798 | |
| Drug | strontium | 1.97e-05 | 68 | 110 | 5 | CID000104798 | |
| Drug | caloxin 1b1 | 2.31e-05 | 2 | 110 | 2 | ctd:C510327 | |
| Drug | fluorescamine | 2.41e-05 | 35 | 110 | 4 | CID000037927 | |
| Drug | mag-fura-2 | 3.01e-05 | 37 | 110 | 4 | CID000123839 | |
| Drug | gramicidin s | 3.01e-05 | 37 | 110 | 4 | CID000073357 | |
| Drug | 8-hydroxycoumarin | 3.03e-05 | 13 | 110 | 3 | CID000122783 | |
| Drug | carbidine | 4.12e-05 | 40 | 110 | 4 | CID000065684 | |
| Drug | C12E8 | 5.01e-05 | 42 | 110 | 4 | CID000123921 | |
| Drug | linopirdine | 5.50e-05 | 43 | 110 | 4 | CID000003932 | |
| Drug | xenon | 6.84e-05 | 88 | 110 | 5 | CID000023991 | |
| Drug | benzoquinone | 7.11e-05 | 209 | 110 | 7 | CID000004650 | |
| Drug | agelasine B | 7.20e-05 | 46 | 110 | 4 | CID006439899 | |
| Drug | milrinone | 9.02e-05 | 150 | 110 | 6 | CID000004197 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 2.83e-09 | 6 | 111 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | tyrosine-protein kinase TEC measurement | 8.37e-05 | 4 | 111 | 2 | EFO_0020830 | |
| Disease | Chromosomal Instability | 3.87e-04 | 8 | 111 | 2 | C1257806 | |
| Disease | Adenoid Cystic Carcinoma | 5.63e-04 | 100 | 111 | 4 | C0010606 | |
| Disease | Anxiety States, Neurotic | 6.13e-04 | 44 | 111 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 6.13e-04 | 44 | 111 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 6.13e-04 | 44 | 111 | 3 | C0003469 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 9.46e-04 | 51 | 111 | 3 | cv:CN043650 | |
| Disease | Disorder of eye | 1.26e-03 | 212 | 111 | 5 | C0015397 | |
| Disease | Intellectual Disability | 1.54e-03 | 447 | 111 | 7 | C3714756 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.84e-03 | 17 | 111 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.84e-03 | 17 | 111 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.84e-03 | 17 | 111 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.84e-03 | 17 | 111 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.84e-03 | 17 | 111 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.84e-03 | 17 | 111 | 2 | C0751781 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.06e-03 | 18 | 111 | 2 | C0751779 | |
| Disease | hearing loss | 2.08e-03 | 67 | 111 | 3 | EFO_0004238 | |
| Disease | pulse pressure measurement | CRADD FBRSL1 ANO1 TRIOBP IRF5 CHD2 INO80 TEC DHX8 EML1 ATP2B1 OBI1 TEC | 2.22e-03 | 1392 | 111 | 13 | EFO_0005763 |
| Disease | rheumatoid arthritis (is_marker_for) | 2.27e-03 | 69 | 111 | 3 | DOID:7148 (is_marker_for) | |
| Disease | cystathionine measurement | 2.30e-03 | 19 | 111 | 2 | EFO_0010474 | |
| Disease | Osteochondrodysplasias | 2.30e-03 | 19 | 111 | 2 | C0029422 | |
| Disease | Nonsyndromic genetic hearing loss | 2.98e-03 | 76 | 111 | 3 | cv:C5680182 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.08e-03 | 22 | 111 | 2 | C3711387 | |
| Disease | hemoglobin change measurement | 3.08e-03 | 22 | 111 | 2 | EFO_0600027 | |
| Disease | Bronchiectasis | 3.08e-03 | 22 | 111 | 2 | C0006267 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEWIKADKIVRPADK | 616 | Q4LE39 | |
| KLREKWVINPEESKL | 201 | Q7L0X2 | |
| ALKPHERKEKWERRL | 101 | Q9HCM7 | |
| KAEDFRKLWKTPPRE | 531 | Q86XL3 | |
| ELRTKWDKVKQLVPI | 606 | P35609 | |
| EIEEKINKIRWLPQK | 91 | P63151 | |
| PGLEESKEVIKWKRL | 576 | Q8N157 | |
| LRRDKWVVEGKLRKL | 1241 | Q9UIF8 | |
| CKPDLKKLVWIVSRR | 261 | Q16589 | |
| RKIAWEKKEDTPREI | 381 | Q9BXX3 | |
| RLVKELEAKKIRWGQ | 3381 | Q96DT5 | |
| VSDPLSDLKWKEVKR | 56 | Q13362 | |
| ICTRLSPKKIIEKWV | 221 | O14874 | |
| SPKKIIEKWVDFARR | 226 | O14874 | |
| PLLKAKRRRVSKDDW | 1156 | Q6W2J9 | |
| RWEKIAEAVPGRTKK | 576 | Q99543 | |
| EQERIDKIWPKLRVL | 751 | P20020 | |
| EIEQERLDKVWPKLR | 746 | Q16720 | |
| EKLDKIWPKLRVLAR | 741 | P23634 | |
| KDVIRKPPRNWKDSI | 756 | P98194 | |
| DRLTPEERTKALKKW | 1336 | Q9P241 | |
| KVEREAKTWIEKPRG | 11 | Q96IT6 | |
| LRKKEKRATSWPDLI | 141 | P15918 | |
| RLARLIKEAVWEKIK | 601 | Q5U651 | |
| RRRKVWLSIVKKELP | 276 | Q9ULG1 | |
| IVRRYIKDWLERKKP | 186 | Q0GE19 | |
| WDIKREHDVRKPKEL | 1286 | Q86UL8 | |
| LEELRKTKEVPWRRD | 306 | Q96Q35 | |
| CRRELPEVKKKWSDL | 61 | Q69YI7 | |
| PEVKKKWSDLKTEVR | 66 | Q69YI7 | |
| RLPENRISKEKDVLW | 86 | Q9NPH3 | |
| RISKEKDVLWFRPTL | 91 | Q9NPH3 | |
| GRVILKIEKEEWKTL | 61 | Q96DD0 | |
| PRSSWKERILKAKVV | 66 | Q9NVH0 | |
| IPKEKDEKIAWALSR | 81 | Q04760 | |
| RNKEIKDALWKVLER | 296 | Q8NGJ0 | |
| INRERWRAKVPKEEK | 516 | Q14123 | |
| RRWVTKKIKVEFEEL | 116 | Q8NEN9 | |
| TWEKPFAKIIEDLRR | 356 | Q96J66 | |
| KINPETVAEWKKKLR | 151 | Q5W0B1 | |
| WGIKVERIEIKDVRL | 256 | Q9NP85 | |
| KKPQDQLVIERERKW | 1336 | Q8WWI1 | |
| IDVKDWPIQIRDKRK | 1371 | Q5S007 | |
| IARWLTKIEVPKTEK | 586 | Q5XXA6 | |
| WSPELKKERVLRKEE | 186 | O15083 | |
| EEWPDRKPREKKLIT | 401 | Q13568 | |
| SLRKLREKVDPNLWI | 551 | Q495T6 | |
| PRIKWSRVSKEKEVV | 71 | P16112 | |
| LSKLPRPWIVDEKKD | 616 | Q86YT6 | |
| KIRRLKGWVLLEDET | 61 | Q49AM1 | |
| RVEERKKWPERLSAL | 811 | Q9Y4L1 | |
| IRVKAEPFIKWLKEA | 371 | P55010 | |
| EVRPKGRQRKLWKDE | 201 | O15234 | |
| PIEAECRKWEEKLIR | 1061 | Q8TD57 | |
| QWIEKRRGEKLDKVL | 376 | P19525 | |
| EILRTLTVWKKSPEK | 531 | P19525 | |
| WKTVREERKKPTEEE | 366 | Q9H8Y5 | |
| KDWDEIIPEEQRKKV | 1041 | O14647 | |
| AEIPKTIKKLRWFDE | 621 | Q9P2H0 | |
| LQEFPWVREKLKKAR | 76 | P78560 | |
| RSWRKKKVSIIDAPD | 291 | Q8ND71 | |
| EFWVDGKPRVRKSLK | 126 | P02741 | |
| VKTPLWKKETEELRA | 6 | Q8WW18 | |
| ELRKIREKEEWIKLD | 376 | Q8NA54 | |
| VWDRCEARVKKTKEP | 441 | Q5JRC9 | |
| DDEEWKPTKLVKVSR | 1066 | O95239 | |
| SSDRPVVKWQLKRDK | 61 | Q14CZ8 | |
| EAKVELPTKRLKLEW | 211 | O00423 | |
| NWIEEATKRVPKLKK | 161 | Q4LDG9 | |
| QAWKLPESERKKIIR | 4316 | Q9NZJ4 | |
| KVWIPDDLRKRLNIE | 411 | O43933 | |
| QWLKREKEEEPVAKR | 336 | Q96FZ2 | |
| PVEALKWEERKCLIL | 166 | Q9UK39 | |
| RWIKLDLKTELPRDT | 621 | Q8N1G2 | |
| LERKRLTRISDPEKW | 386 | Q14562 | |
| RELDELKPWIEKTVK | 6 | O43395 | |
| RFWLAVEDLKKRPIK | 361 | P49802 | |
| RWKLLKDSDKIPFIR | 96 | Q06945 | |
| KPERKIQFREKVLWT | 21 | Q9H9S3 | |
| KTKDWLKGLREEIIR | 966 | O15056 | |
| PQSRDLWVKKLKEEI | 96 | P42680 | |
| SREEGIKWIKKERLP | 116 | Q8NE09 | |
| IKWIKKERLPAFLES | 121 | Q8NE09 | |
| DVWKKNEVKDLLRRL | 1511 | Q8IVG5 | |
| PKVFQKIWLERDRKL | 251 | Q9H1U9 | |
| KRRQEEWEKVRKPED | 26 | Q9GZU8 | |
| QLLRKVDPAKDRELW | 446 | O60861 | |
| EEPIKTIRNWLKEKL | 86 | A6NLE4 | |
| DLTTAEKLKRETPWK | 1006 | Q13621 | |
| EKLKRETPWKITDAE | 1011 | Q13621 | |
| PKVFQKIWLERDRKL | 251 | Q3SY17 | |
| KKKQPLDRRETERQW | 61 | Q9BZV3 | |
| EERKRENLRTPWKPK | 731 | Q9BXB5 | |
| TLEKEPRTFKAKELW | 56 | Q9BRX8 | |
| IEKKWQELEKLPLRE | 2026 | Q9H2D6 | |
| REEGWKEVVRRSKKL | 1686 | Q8IWZ3 | |
| KKIKLDTPEEIARWR | 226 | Q9UHK0 | |
| KELKGEKVIRPEWIV | 101 | Q9UBZ9 | |
| TWKEVKKIIKEDPRC | 976 | O14776 | |
| PKAKIVVTVWKREIE | 166 | Q8WVR3 | |
| EKIIDKISPEKLVEW | 256 | Q9UIV8 | |
| KERIQKERKEKIWDP | 126 | P29144 | |
| KERKEKIWDPVHRVA | 131 | P29144 | |
| PERLERQKKISWLKE | 401 | Q96SB8 | |
| VEKPEWKKFIEERLL | 306 | Q5HYM0 | |
| LRWRPSRKSEKAKIL | 51 | Q4KWH8 | |
| LISKLERRAAPWIKD | 381 | O60290 | |
| PAWKREILERKRAKL | 16 | Q4KMQ1 | |
| EIILWRKAPEKLRKQ | 291 | O75436 | |
| LTDEIRRKVWPKLLN | 61 | Q96BZ9 | |
| KSTIALRLWVEDPKK | 471 | Q9Y3S1 | |
| RVKELVSRELKDWPK | 576 | Q5VYS8 | |
| VSRELKDWPKKRIAI | 581 | Q5VYS8 | |
| KILRPPVEKWKRQDD | 1431 | Q5VYS8 | |
| PVEKWKRQDDKDLRE | 1436 | Q5VYS8 | |
| KQEPTWKTKIADRLK | 1756 | Q5T5U3 | |
| WKTKIADRLKLRPRA | 1761 | Q5T5U3 | |
| WRKRETVLRKEEEKL | 246 | Q07283 | |
| AVEPINELLRDKWRK | 451 | Q9HBA0 | |
| LEQRKEPWKVKRQEA | 56 | B4DX44 | |
| VRHLTDWIKKARPIK | 1966 | Q13402 | |
| VKAEDLLRKPTIKWF | 81 | Q00872 |